Article info

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
  1. Sudha Visvanathan, Centocor Research and Development, Inc., 200 Great Valley Parkway, Mailstop RA-1-4; Malvern, PA 19355, USA; svisvana{at}cntus.jnj.com
View Full Text

Citation

Visvanathan S, van der Heijde D, Deodhar A, et al
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

Publication history

  • Accepted March 16, 2008
  • First published May 21, 2008.
Online issue publication 
January 12, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.